Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Yu, De cai ^a   Chen, Jun ^a   Sun, Xi tai ^a   Zhuang, Lin yuan ^a   Jiang, Chun ping ^a   Ding, Yi tao ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2; ENDOSTATIN; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; ANGIOGENIC FACTOR; TUMOR MARKER;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STEM CELL; ANIMAL; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TISSUE MICROARRAY; TRANSPLANTATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CARCINOMA, HEPATOCELLULAR; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955538262     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-435     Document Type: Article

References (35)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
2. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201. 10.1038/nm1101-1194, 11689883.
3. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712. 10.1038/nm0603-702, 12778169.
4. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, Wöll E, Kähler CM. CD133 positive endothelial progenitor cells contribute to the tumor vasculature in non-small cell lung cancer. J Clin Pathol 2004, 57:965-969. 10.1136/jcp.2004.016444, 1770433, 15333659.
5. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006, 66:7341-7347. 10.1158/0008-5472.CAN-05-4654, 16849585.
6. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003, 9:789-795. 10.1038/nm871, 12740570.
7. Beaudry P, Force J, Naumov GN, Wang A, Baker CH, Ryan A, Soker S, Johnson BE, Folkman J, Heymach JV. Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res 2005, 11:3514-3522. 10.1158/1078-0432.CCR-04-2271, 15867254.
8. Kuroi K, Toi M. Circulating angiogenesis regulators in cancer patients. Int J Biol Markers 2001, 16:5-26.
9. Yu DC, Sun XT, Qiu YD, Zhou JX, Wu YF, Zhuang LY, Chen J, Ding YT. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 2007, 13:3814-3824. 10.1158/1078-0432.CCR-06-2594, 17606712.
10. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, Varner J. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006, 116:652-662. 10.1172/JCI24751, 1378185, 16498499.
11. Roeb E, Matern S. Fibronectin--a key substance in pathogenesis of liver cirrhosis?. Leber Magen Darm 1993, 23:239-242.
12. Lv P, Paul SC, Xiao Y, Liu S, Luo H. Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis. Mediators Inflamm 2006, 93253. 1618940, 17047296.
13. Yigit IP, Hacievliyagil SS, Seckin Y, Oner RI, Karincaoglu M. The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci 2008, 53:1951-1956. 10.1007/s10620-007-0100-2, 18080769.
14. Yao YZ, Pan YM, Chen J, Sun XT, Qiu YD, Ding Y. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinoma: analysis using tissue microarray and comparison with CD34 and VEGF. Ann Clin Lab Sci 2007, 37:39-48.
15. UICC (International Union Against Cancer) TNM classification of malignant tumors. 2002, 131-138. NewYork, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss, Sobin LH, Wittekind Ch, 6, UICC (International Union Against Cancer).
16. Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers. J Pathol 2004, 204:101-109. 10.1002/path.1612, 15307143.
17. Ferrari A, Hannouche D, Oudina K, Bourguignon M, Meunier A, Sedel L, Petite H. In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J Biomed Mater Res 2001, 56:361-367. 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4, 11372053.
18. Ding YT, Kumar S, Yu DC. The role of endothelial progenitor cells in tumor vasculogenesis. Pathobiology 2006, 75:265-273.
19. Yu DC, Zhuang LY, Sun XT, Chen J, Yao YZ, Meng K, Ding YT. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. BMC Cancer 2007, 7:122e.
20. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265. 398426, 15124016.
21. Shinde Patil VR, Friedrich EB, Wolley AE, Gerszten RE, Allport JR, Weissleder R. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma. Neoplasia 2006, 7:234-240.
22. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353. 10.1161/01.RES.0000137877.89448.78, 15321944.
23. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002, 29(Suppl 16):15-18.
24. Jeon O, Song SJ, Bhang SH, Choi CY, Kim MJ, Kim BS. Additive effect of endothelial progenitor cell mobilization and bone marrow mononuclear cell transplantation on angiogenesis in mouse schemic limbs. J Biomed Sci 2007, 14:323-330. 10.1007/s11373-007-9145-7, 17265168.
25. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93:980-989. 10.1161/01.RES.0000099245.08637.CE, 14525810.
26. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637. 10.1016/S0092-8674(02)00754-7, 2826110, 12062105.
27. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, Nabika T, Nagasue N. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998, 27:1554-1562. 10.1002/hep.510270613, 9620326.
28. Mathonnet M, Descottes B, Valleix D, Labrousse F, Denizot Y. VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 2006, 12:830-831.
29. Deli G, Jin CH, Mu R, Yang S, Liang Y, Chen D, Makuuchi M. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 2005, 11:960-963.
30. Guirouilh J, Le Bail B, Boussarie L, Balabaud C, Bioulac-Sage P, Desmoulière A, Schuppan D, Rosenbaum J. Expression of hepatocyte growth factor in human hepatocellular carcinoma. J Hepatol 2001, 34:78-83. 10.1016/S0168-8278(00)00014-3, 11211911.
31. Rahman MA, Dhar DK, Yamaguchi E, Maruyama S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H, Nagasue N. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res 2001, 7:1325-1332.
32. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, Sun HC. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008, 26:2707-2716. 10.1200/JCO.2007.15.6521, 18509183.
33. Liu K, He X, Lei XZ, Zhao LS, Tang H, Liu L, Lei BJ. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003, 9:1946-1949.
34. Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am J Physiol 1990, 258(2 Pt 2):460-465.
35. Matsunaga Y, Koda M, Murawaki Y. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Res Commun Mol Pathol Pharmacol 2004, 115-116:143-150.